# IRX2

## Overview
The IRX2 gene encodes the iroquois homeobox 2 protein, a transcription factor belonging to the Iroquois homeobox gene family. This protein is characterized by a unique homeodomain structure and a conserved Iro-box motif, which are critical for its function in regulating gene expression during development (Vitharanage2024Role; Kim2012Iroquois). IRX2 plays a pivotal role in pattern formation and tissue specification, particularly within the nervous system and mammary gland, and is involved in various developmental processes across multiple tissues (Lewis1999Regulated; Werner2015Iroquois). The gene's expression is intricately regulated by chromatin loop structures, facilitating its co-regulation with other Iroquois genes (Tena2011An; Vitharanage2024Role). Clinically, IRX2 is implicated in several cancers, where its expression levels can influence tumor progression and patient prognosis, highlighting its potential as a therapeutic target (LIU2014Knockdown; Werner2015Iroquois).

## Structure
The IRX2 protein is a member of the Iroquois homeobox gene family and is characterized by a unique homeodomain structure. This homeodomain includes three extra amino acids between the first and second alpha helices, distinguishing it from typical homeodomain proteins (Vitharanage2024Role; Kim2012Iroquois). The IRX2 protein also contains a conserved 13 amino acid motif known as the Iro-box in the carboxyl-terminal region, although its specific function remains unclear (Vitharanage2024Role; Kim2012Iroquois).

The primary structure of the IRX2 protein is encoded by a 1.8-kb cDNA, resulting in a 417-amino acid protein (Lewis1999Regulated). The protein structure includes a homeodomain, a hexapeptide-like motif, acidic and poly-proline regions, and an IRO box (Lewis1999Regulated). Two main transcripts, IRX-2a and IRX-2b, have been identified, with IRX-2a containing the homeobox, suggesting alternative splicing (Lewis1999Regulated).

The IRX2 protein is part of a cluster with IRX1 and IRX4 on human chromosome 5, and its expression is regulated by chromatin loop structures, which facilitate the co-regulation of IRX1 and IRX2 (Tena2011An; Vitharanage2024Role). However, specific details on the tertiary or quaternary structures, as well as post-translational modifications, are not provided in the available context.

## Function
The IRX2 gene, a member of the Iroquois homeobox family, plays a significant role in the regulation of gene expression during human development. It is involved in pattern formation and tissue specification, particularly in the nervous system and mammary gland development. In the human breast, IRX2 is expressed in ductal and lobular epithelium, suggesting a role in epithelial cell differentiation and the regulation of ductal and lobular proliferation (Lewis1999Regulated; Werner2015Iroquois). 

IRX2 is also expressed in other tissues, including the lung, uterus, salivary gland, and kidney, indicating its involvement in various developmental processes beyond the breast (Lewis1999Regulated). The gene produces two main transcripts, IRX-2a and IRX-2b, with IRX-2a containing a homeobox, which is crucial for its function as a transcription factor (Lewis1999Regulated). 

In the context of neurogenesis, IRX2 is activated by WNT signaling and acts as a repressor of bone morphogenetic protein BMP-4, which is a neural antagonist (Adamowicz2006Frequent). This suggests that IRX2 may have a role in promoting neural fate and inhibiting epidermal differentiation.

## Clinical Significance
The IRX2 gene is implicated in various cancers, with its expression levels and genetic alterations influencing disease progression and patient outcomes. In breast cancer, low IRX2 expression is associated with high tumor grade, positive lymph node status, and the presence of disseminated tumor cells in the bone marrow, which are predictors of metastatic relapse. This suggests a role for IRX2 as a metastasis suppressor by inhibiting cellular motility and chemokine secretion (Werner2015Iroquois). Conversely, high IRX2 expression is linked to larger tumor size and may have oncogenic functions, particularly in the presence of PIK3CA mutations (Werner2015Iroquois).

In osteosarcoma, IRX2 expression is significantly increased compared to normal tissues, correlating with tumor progression and poorer prognosis. Knockdown of IRX2 in osteosarcoma cells suppresses proliferation and invasion, indicating its role in promoting these processes through the AKT and MMP9 signaling pathways (LIU2014Knockdown).

In non-small cell lung cancer, IRX2 expression varies between subtypes, with higher expression linked to better outcomes in lung adenocarcinoma but poorer outcomes in lung squamous cell carcinoma, potentially due to differences in cellular localization (Wang2020Comprehensive). In soft tissue sarcomas, IRX2 is frequently amplified and highly expressed, particularly in malignant peripheral nerve sheath tumors, suggesting a role in tumor pathogenesis (Adamowicz2006Frequent).


## References


1. (Wang2020Comprehensive) Comprehensive Analysis of the Expression and Prognosis for IRXs&amp;nbsp;in Non-small Cell Lung Cancer. This article has 1 citations.

[2. (Adamowicz2006Frequent) Martyna Adamowicz, Bernhard Radlwimmer, Ralf J. Rieker, Daniel Mertens, Matthias Schwarzbach, Peter Schraml, Axel Benner, Peter Lichter, Gunhild Mechtersheimer, and Stefan Joos. Frequent amplifications and abundant expression oftrio,nkd2, andirx2 in soft tissue sarcomas. Genes, Chromosomes and Cancer, 45(9):829–838, 2006. URL: http://dx.doi.org/10.1002/gcc.20343, doi:10.1002/gcc.20343. This article has 46 citations.](https://doi.org/10.1002/gcc.20343)

[3. (Werner2015Iroquois) Stefan Werner, Hauke Stamm, Mutiha Pandjaitan, Dirk Kemming, Benedikt Brors, Klaus Pantel, and Harriet Wikman. Iroquois homeobox 2 suppresses cellular motility and chemokine expression in breast cancer cells. BMC Cancer, November 2015. URL: http://dx.doi.org/10.1186/s12885-015-1907-4, doi:10.1186/s12885-015-1907-4. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12885-015-1907-4)

[4. (Kim2012Iroquois) Kyoung-Han Kim, Anna Rosen, Benoit G. Bruneau, Chi-chung Hui, and Peter H. Backx. Iroquois homeodomain transcription factors in heart development and function. Circulation Research, 110(11):1513–1524, May 2012. URL: http://dx.doi.org/10.1161/CIRCRESAHA.112.265041, doi:10.1161/circresaha.112.265041. This article has 83 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1161/CIRCRESAHA.112.265041)

[5. (LIU2014Knockdown) TIELONG LIU, WEIWEI ZHOU, FEI ZHANG, GUODONG SHI, HONGLIN TENG, JIANRU XIAO, and YAN WANG. Knockdown of irx2 inhibits osteosarcoma cell proliferation and invasion by the akt/mmp9 signaling pathway. Molecular Medicine Reports, 10(1):169–174, May 2014. URL: http://dx.doi.org/10.3892/mmr.2014.2215, doi:10.3892/mmr.2014.2215. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/mmr.2014.2215)

[6. (Tena2011An) Juan J. Tena, M. Eva Alonso, Elisa de la Calle-Mustienes, Erik Splinter, Wouter de Laat, Miguel Manzanares, and José Luis Gómez-Skarmeta. An evolutionarily conserved three-dimensional structure in the vertebrate irx clusters facilitates enhancer sharing and coregulation. Nature Communications, May 2011. URL: http://dx.doi.org/10.1038/ncomms1301, doi:10.1038/ncomms1301. This article has 67 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncomms1301)

[7. (Lewis1999Regulated) Michael T. Lewis, Sarajane Ross, Phyllis A. Strickland, C. John Snyder, and C. W. Daniel. Regulated expression patterns of irx-2 , an iroquois-class homeobox gene, in the human breast. Cell and Tissue Research, 296(3):549–554, May 1999. URL: http://dx.doi.org/10.1007/s004410051316, doi:10.1007/s004410051316. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s004410051316)

8. (Vitharanage2024Role) Role of Iroquois homeobox 4 (IRX4) isoforms in prostate cancer. This article has 0 citations.